Lactating rats were treated for 48 h with bromocriptine (to inhibit prolactin release) or bromocriptine together with an antiserum to rat GH. Animals given the combined treatment were also supplemented concurrently with bovine GH (bGH) or human insulin-like growth factor-I (hIGF-I). The results indicate that the cessation of lactation brings about rapid changes in the activities of the enzymes involved in cholesterol metabolism within the mammary gland with a definite switch from synthesis to storage. Supplementation with bGH alone was sufficient to maintain cholesterol synthesis at control levels and could also significantly inhibit storage of the sterol as its ester. In the absence of GH, hIGF-I partially supported cholesterol synthesis but had no effect on its conversion to the ester. On a whole-tissue basis, enzyme activities could be correlated with the physiological effects of the anti-hormone treatments.
Introduction
During lactation in the rat, milk secretion is maintained under the control of two hormones, prolactin and growth hormone (GH) (Tucker, 1974) . While GH is clearly important in ruminants and has been the subject of intensive research (Forsyth 1986 , Johnsson & Hart 1986 , Bauman & Vernon 1993 , prolactin has been thought to be the more important of the two hormones in rodents (Cowie 1969 , Shaar & Clemens 1972 , Sinha et al. 1974 ).
However, the use of the drug bromocriptine to inhibit prolactin release by the pituitary and the availability of a specific antiserum to rat GH (anti-rGH) has allowed the effects of the two hormones to be studied separately (Madon et al. 1986) and it is now clear that rGH alone can support about 50% of lactation. It has also been shown, in the rat, that blocking the activities of both prolactin and GH, using bromocriptine and anti-rGH together, causes reciprocal changes in the activities of lipoprotein lipase, acetyl-CoA carboxylase and fatty acid synthase, the enzymes controlling fatty acid uptake and de novo synthesis (Barber et al. I992a, b) . Thus, while the mammary gland enzymes decreased in activity, those in adipose tissue increased and these effects were partially reversed when GH was administered to the rats at the same time as the anti-hormone agents.
Although cholesterol comprises about 0-6% only of the total lipids in milk, its importance lies in its role as an essential structural component of the milk-fat globule membrane and in the replenishment of cell membrane cholesterol during a period of high turnover. During peak lactation, the rat can produce up to 40 ml of milk per day (Munday Se Hardie 1987) containing around 25 mg chol¬ esterol (Myant 1981) . Although it has been calculated that only 40% of rat milk cholesterol could originate by de novo synthesis within the mammary gland (Gibbins et al. 1983) , lactation still imposes a significant synthetic load on the tissue. Cholesterol metabolism in the rat mammary gland is controlled by three main enzymes. 3-Hydroxy-3-methylglutaryl-CoA reductase (HMG-CoA reductase; EC 1.1.1.34) catalyses the rate-determining step in the synthetic pathway whereas acyl-CoAxholesterol acyltransferase (ACAT; EC 2.3.1.26) and cholesteryl ester hydrolase (CEH; EC 3.1.1.13) control the degree of storage of the sterol as its ester. Previous work has shown that these enzymes respond to changes in the lactational state of the animal. Mammary gland ACAT activity decreased significantly between early and mid lactation and was greatly increased after weaning (Shand & West 199lit ). When milk secretion was inhibited by the admin¬ istration of a combination of bromocriptine and anti-rGH, HMG-CoA reductase was greatly inhibited whereas ACAT activity was increased (Flint et al. 1992) , could substitute to any extent for GH in animals in which lactation had been inhibited by the use of the two anti-hormone agents.
Materials and Methods

Materials
Bromocriptine was obtained from Sandoz, Basel, Switzerland and the highly specific anti-rGH was pre¬ pared as described by Madon et al. (1986) (1957) . The extracts were dissolved in ethanol, and non-esterified and total cholesterol were assayed by the fluorimetrie method of Gamble et al. (1978) . The concentrations of cholesteryl esters were then calculated by difference.
Results
Total mammary tissue weights and litterweight gains The total weights of mammary tissue excised (g/animal; mean ± s.e.m. of six) from the five treatment groups were as follows: controls, 13-8 ± 0-8; bromocriptine, 11*7 ± 0-7; combined anti-hormone agents, 10-7 ± 0-8; 'combined'+ bGH, 11-9 ±1-4; 'combined'+hIGF-I, 9-2 ±1-1. Only in the two groups treated with the combined antihormone agents and the combined anti-hormone agents supplemented with hIGF-I were the total tissue weights significantly lower ( <0 5) than in controls. (Flint & Gardner 1994) . Concurrent administration of bGH to these 'combined-treatment' animals restored milk yield to about 70% of the control level, whereas hIGF-I was ineffective.
HMG-CoA reductase activity Neutral CEH activity Microsomal cholesterol and cholesteryl esters Whereas the presence of GH alone (in bromocriptinetreated animals) maintained control levels of both sterols (Table 4) , the absence of both GH and prolactin (in animals given the combined anti-hormone treatment) caused significant increases in the microsomal contents of cholesterol (2-0-fold) and cholesteryl esters (2-6-fold) and thus a sharp decrease in the cholesterol/cholesteryl ester ratio. Although administration of either bGH or hIGF-I along with the two anti-hormone agents completely prevented the increase in microsomal cholesterol content, neither bGH nor hIGF-I could prevent the rise in microsomal cholesteryl esters. The differential effects of supplementation with bGH or hIGF-I on the two sterols are reflected in the significantly lower cholesterol/ cholesteryl ester ratios in these rats.
Discussion
The results confirm that the rate of cholesterol synthesis, as shown by HMG-CoA reductase activity, was 55% lower in the presence of GH alone than in control animals and again this reduction compares favourably with the ability of endogenous GH, in the absence of prolactin, to support about 50% of lactation in the rat (Madon et al. 1986 ). In the absence of both hormones, a marked shift to choles¬ terol storage was seen (reduced HMG-CoA reductase and increased ACAT activities), but this change could be partially reversed by concurrent administration of exogen¬ ous GH. Specifically, the activity of HMG-CoA reductase was completely restored by concurrent injection of bGH but there was a significant increase also in enzyme activity when hIGF-I was given. It thus appears that HMG-CoA reductase, the activity of which seems to correlate directly with milk output, is particularly responsive to GH and this observation adds further support to the suggestion that an auxiliary function of GH could be in the production of an energy-rich high-fat milk when prolactin secretion is reduced (Barber et al. I992a,b; Flint & Gardner 1994 , Flint 1995 . The increase in HMG-CoA reductase due to IGF-I is a novel finding since, apart from the observation in the goat (Prosser et al. 1994 ) that direct infusion of either IGF-I or IGF-II or both, led to significant increases in mammary blood flow and milk yield, this would appear to be the first observation of a metabolic effect of an IGF on the mammary gland. Although the effect of IGF-I is much less than GH, perhaps due in part to their relative biological half-lives (Flint et al. 1992) 
